Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion type Assertion NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_head.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion description "[The myotonic disorders, including the myotonic dystrophies (myotonic dystrophy type 1, DM1; myotonic dystrophy type 2, DM2/PROMM/PDM), the muscle channelopathies or non-dystrophic myotonias (chloride, sodium, calcium and potassium channelopathies) are all characterized by myotonia and muscle weakness despite different pathophysiology involved in these disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_provenance.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion evidence source_evidence_literature NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_provenance.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion SIO_000772 15269662 NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_provenance.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion wasDerivedFrom befree-20140225 NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_provenance.
- NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_assertion wasGeneratedBy ECO_0000203 NP526273.RAFWfwAvfyNV-EKytZNSenq1u9_AIDMW_OL--c1fZHi_I130_provenance.